位置:首页 > 蛋白库 > EFHD1_HUMAN
EFHD1_HUMAN
ID   EFHD1_HUMAN             Reviewed;         239 AA.
AC   Q9BUP0; B2RD83; E9PFH3; Q9BTF8; Q9H8I2; Q9HBQ0;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=EF-hand domain-containing protein D1;
DE   AltName: Full=EF-hand domain-containing protein 1;
DE   AltName: Full=Swiprosin-2;
GN   Name=EFHD1; Synonyms=SWS2; ORFNames=PP3051;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ARG-186.
RC   TISSUE=Heart, Placenta, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-186.
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF ASP-103; GLU-114; ASP-139 AND GLU-150.
RX   PubMed=26975899; DOI=10.1016/j.ceca.2016.03.002;
RA   Hou T., Jian C., Xu J., Huang A.Y., Xi J., Hu K., Wei L., Cheng H.,
RA   Wang X.;
RT   "Identification of EFHD1 as a novel Ca(2+) sensor for mitoflash
RT   activation.";
RL   Cell Calcium 59:262-270(2016).
CC   -!- FUNCTION: Acts as a calcium sensor for mitochondrial flash (mitoflash)
CC       activation, an event characterized by stochastic bursts of superoxide
CC       production (PubMed:26975899). May play a role in neuronal
CC       differentiation (By similarity). {ECO:0000250|UniProtKB:Q9D4J1,
CC       ECO:0000269|PubMed:26975899}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:Q9D4J1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BUP0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BUP0-2; Sequence=VSP_045541;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG17248.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF218006; AAG17248.1; ALT_FRAME; mRNA.
DR   EMBL; AK023674; BAB14634.1; -; mRNA.
DR   EMBL; AK310565; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK315442; BAG37830.1; -; mRNA.
DR   EMBL; AC064852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073254; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002449; AAH02449.1; -; mRNA.
DR   EMBL; BC004128; AAH04128.2; -; mRNA.
DR   CCDS; CCDS2497.1; -. [Q9BUP0-1]
DR   CCDS; CCDS58755.1; -. [Q9BUP0-2]
DR   RefSeq; NP_001230181.1; NM_001243252.1. [Q9BUP0-2]
DR   RefSeq; NP_001295324.1; NM_001308395.1.
DR   RefSeq; NP_079478.1; NM_025202.3. [Q9BUP0-1]
DR   AlphaFoldDB; Q9BUP0; -.
DR   SMR; Q9BUP0; -.
DR   BioGRID; 123216; 80.
DR   IntAct; Q9BUP0; 17.
DR   STRING; 9606.ENSP00000264059; -.
DR   iPTMnet; Q9BUP0; -.
DR   PhosphoSitePlus; Q9BUP0; -.
DR   BioMuta; EFHD1; -.
DR   DMDM; 20140222; -.
DR   EPD; Q9BUP0; -.
DR   jPOST; Q9BUP0; -.
DR   MassIVE; Q9BUP0; -.
DR   MaxQB; Q9BUP0; -.
DR   PaxDb; Q9BUP0; -.
DR   PeptideAtlas; Q9BUP0; -.
DR   PRIDE; Q9BUP0; -.
DR   ProteomicsDB; 20103; -.
DR   ProteomicsDB; 79116; -. [Q9BUP0-1]
DR   Antibodypedia; 34436; 305 antibodies from 30 providers.
DR   DNASU; 80303; -.
DR   Ensembl; ENST00000264059.8; ENSP00000264059.3; ENSG00000115468.13. [Q9BUP0-1]
DR   Ensembl; ENST00000409613.5; ENSP00000386556.1; ENSG00000115468.13. [Q9BUP0-2]
DR   GeneID; 80303; -.
DR   KEGG; hsa:80303; -.
DR   MANE-Select; ENST00000264059.8; ENSP00000264059.3; NM_025202.4; NP_079478.1.
DR   UCSC; uc002vtc.4; human. [Q9BUP0-1]
DR   CTD; 80303; -.
DR   DisGeNET; 80303; -.
DR   GeneCards; EFHD1; -.
DR   HGNC; HGNC:29556; EFHD1.
DR   HPA; ENSG00000115468; Tissue enhanced (brain).
DR   MIM; 611617; gene.
DR   neXtProt; NX_Q9BUP0; -.
DR   OpenTargets; ENSG00000115468; -.
DR   PharmGKB; PA134935372; -.
DR   VEuPathDB; HostDB:ENSG00000115468; -.
DR   eggNOG; KOG0041; Eukaryota.
DR   GeneTree; ENSGT00390000012058; -.
DR   HOGENOM; CLU_094429_0_0_1; -.
DR   InParanoid; Q9BUP0; -.
DR   OMA; RQDINEG; -.
DR   OrthoDB; 1511376at2759; -.
DR   PhylomeDB; Q9BUP0; -.
DR   TreeFam; TF320736; -.
DR   PathwayCommons; Q9BUP0; -.
DR   SignaLink; Q9BUP0; -.
DR   BioGRID-ORCS; 80303; 10 hits in 1077 CRISPR screens.
DR   ChiTaRS; EFHD1; human.
DR   GenomeRNAi; 80303; -.
DR   Pharos; Q9BUP0; Tbio.
DR   PRO; PR:Q9BUP0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9BUP0; protein.
DR   Bgee; ENSG00000115468; Expressed in inferior olivary complex and 189 other tissues.
DR   ExpressionAtlas; Q9BUP0; baseline and differential.
DR   Genevisible; Q9BUP0; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; TAS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0061891; F:calcium ion sensor activity; IMP:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:1900069; P:regulation of cellular hyperosmotic salinity response; IMP:UniProtKB.
DR   CDD; cd00051; EFh; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR040365; EFHD1/2.
DR   PANTHER; PTHR13025; PTHR13025; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion inner membrane; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..239
FT                   /note="EF-hand domain-containing protein D1"
FT                   /id="PRO_0000073643"
FT   DOMAIN          90..125
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          126..161
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..22
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..45
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         103
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         107
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         114
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         139
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305"
FT   BINDING         141
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305"
FT   BINDING         143
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305"
FT   BINDING         145
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305"
FT   BINDING         150
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..101
FT                   /note="MASEELACKLERRLRREEAEESGPQLAPLGAPAPEPKPEPEPPARAPTASAD
FT                   AELSAQLSRRLDINEGAARPRRCRVFNPYTEFPEFSRRLIKDLESMFKL -> MGELQ
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045541"
FT   VARIANT         186
FT                   /note="K -> R (in dbSNP:rs11550699)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_047966"
FT   MUTAGEN         103
FT                   /note="D->A: In mtEFHD1; abolished ability to enhance
FT                   mitoflash activity; when associated with K-114; A-139 and
FT                   K-150."
FT                   /evidence="ECO:0000269|PubMed:26975899"
FT   MUTAGEN         114
FT                   /note="E->K: In mtEFHD1; abolished ability to enhance
FT                   mitoflash activity; when associated with A-103; A-139 and
FT                   K-150."
FT                   /evidence="ECO:0000269|PubMed:26975899"
FT   MUTAGEN         139
FT                   /note="D->A: In mtEFHD1; abolished ability to enhance
FT                   mitoflash activity; when associated with A-103; K-114 and
FT                   K-150."
FT                   /evidence="ECO:0000269|PubMed:26975899"
FT   MUTAGEN         150
FT                   /note="E->K: In mtEFHD1; abolished ability to enhance
FT                   mitoflash activity; when associated with A-103; K-114 and
FT                   A-139."
FT                   /evidence="ECO:0000269|PubMed:26975899"
SQ   SEQUENCE   239 AA;  26928 MW;  1712F79E2A3CC007 CRC64;
     MASEELACKL ERRLRREEAE ESGPQLAPLG APAPEPKPEP EPPARAPTAS ADAELSAQLS
     RRLDINEGAA RPRRCRVFNP YTEFPEFSRR LIKDLESMFK LYDAGRDGFI DLMELKLMME
     KLGAPQTHLG LKSMIKEVDE DFDGKLSFRE FLLIFHKAAA GELQEDSGLM ALAKLSEIDV
     ALEGVKGAKN FFEAKVQALS SASKFEAELK AEQDERKREE EERRLRQAAF QKLKANFNT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024